Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts
- PMID: 27150963
- DOI: 10.2174/1573406412666160506150924
Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts
Abstract
Background: The Morita-Baylis-Hillman reaction is an organocatalyzed chemical transformation that allows access to small poly-functionalized molecules and has considerable synthetic potential and promising biological profiles. The Morita-Baylis-Hillman adducts (MBHA) are a new class of bioactive compounds and highlight its potentialities to the discovery of new cheaper and efficient drugs, e.g. as anti-Leishmania chagasi and Leishmania amazonensis, anti- Trypanosoma cruzi, anti-Plasmodium falciparum and Plasmodium berghei, lethal against Biomphalaria glabrata, antibacterial, antifungal, herbicide and others.
Methods: The goal of this work is to describe the primary cytotoxic activities against strains of human leukemia HL-60 cell line for thirty-four Morita-Baylis- Hillman adducts (MBHA), followed by a Quantitative Structure-Activity Relationships study (QSAR).
Results: The conventional or microwave-assisted syntheses of MBHA, derived from substituted aromatics or Isatin, were performed in good to excellent yields (70-100%) in short reaction times, using protocols recently developed by us. Isatin derivatives, MBHA 31 and 32, were the most active in this congener series of compounds, with IC50 values of 10.8 μM and 7.8 μM, respectively. The primary cytotoxic activities against chronic leukemia cells (K562) were also evaluated to these two most active compounds (MBHA 31 and 32), presenting IC50 values of 53 μM and 43 μM respectively. QSAR study was performed considering 3D, 2D and constitutional molecular descriptors. These were selected from Ordered Predictor Selection algorithm and submitted to Partial Least Squares Modeling.
Conclusion: We present an interesting investigation about cytotoxic activities on human leukemia cell line (HL-60) for 34 synthetic MBHA. In a good way we discovered that the most cytotoxic compounds (31-32, 10.8 μM and 7.8 μM respectively) were also prepared quantitatively (100% yields) in a short reaction time using microwave irradiation. We demonstrate that 31 and 32 induced apoptosis and not necrosis in HL-60 cells, observed by externalization of PS and increase Anexin-V positive cells. Quantitative Structure-Activity Relationships considering 3D, 2D and constitutional descriptors provided a robust and predictive PLS model, in accordance with SAR observations.
Similar articles
-
Synthesis, anti-proliferative activity, theoretical and 1H NMR experimental studies of Morita-Baylis-Hillman adducts from isatin derivatives.Mol Divers. 2020 Feb;24(1):265-281. doi: 10.1007/s11030-019-09950-7. Epub 2019 Apr 6. Mol Divers. 2020. PMID: 30955150
-
Morita-Baylis-Hillman adducts: biological activities and potentialities to the discovery of new cheaper drugs.Bioorg Med Chem. 2012 Jul 1;20(13):3954-71. doi: 10.1016/j.bmc.2012.04.061. Epub 2012 May 9. Bioorg Med Chem. 2012. PMID: 22632793
-
Efficient synthesis of 16 aromatic Morita-Baylis-Hillman adducts: Biological evaluation on Leishmania amazonensis and Leishmania chagasi.Bioorg Chem. 2010 Dec;38(6):279-84. doi: 10.1016/j.bioorg.2010.08.002. Epub 2010 Sep 19. Bioorg Chem. 2010. PMID: 20855101
-
Biological Activities of Morita-Baylis-Hillman Adducts (MBHA).Mini Rev Med Chem. 2023;23(17):1691-1710. doi: 10.2174/1389557523666230202103719. Mini Rev Med Chem. 2023. PMID: 36733204 Review.
-
Synthesis, biological activities, and structure-activity relationships of Morita-Baylis-Hillman adducts: An update.Arch Pharm (Weinheim). 2024 Oct;357(10):e2400372. doi: 10.1002/ardp.202400372. Epub 2024 Jul 4. Arch Pharm (Weinheim). 2024. PMID: 38963326 Review.
Cited by
-
Synthesis, anti-proliferative activity, theoretical and 1H NMR experimental studies of Morita-Baylis-Hillman adducts from isatin derivatives.Mol Divers. 2020 Feb;24(1):265-281. doi: 10.1007/s11030-019-09950-7. Epub 2019 Apr 6. Mol Divers. 2020. PMID: 30955150
-
Morita-Baylis-Hillman Adducts Display Anti-Inflammatory Effects by Modulating Inflammatory Mediator Expression in RAW264.7 Cells.Mediators Inflamm. 2017;2017:6898505. doi: 10.1155/2017/6898505. Epub 2017 Jul 12. Mediators Inflamm. 2017. PMID: 28785138 Free PMC article.
-
A New MBH Adduct as an Efficient Ligand in the Synthesis of Metallodrugs: Characterization, Geometrical Optimization, XRD, Biological Activities, and Molecular Docking Studies.Molecules. 2022 Nov 23;27(23):8150. doi: 10.3390/molecules27238150. Molecules. 2022. PMID: 36500251 Free PMC article.
-
Morita-Baylis-Hillman Adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) Modulates Inflammatory Process In vitro and In vivo.Inflammation. 2021 Jun;44(3):899-907. doi: 10.1007/s10753-020-01385-9. Epub 2020 Nov 24. Inflammation. 2021. PMID: 33236262
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous